PENNISI, MARIA STELLA
 Distribuzione geografica
Continente #
EU - Europa 332
NA - Nord America 104
AS - Asia 54
AF - Africa 53
SA - Sud America 3
Totale 546
Nazione #
IT - Italia 175
US - Stati Uniti d'America 100
FR - Francia 75
CI - Costa d'Avorio 42
IE - Irlanda 36
IN - India 15
HK - Hong Kong 12
UA - Ucraina 11
CN - Cina 8
CZ - Repubblica Ceca 6
NL - Olanda 5
VN - Vietnam 5
DE - Germania 4
EG - Egitto 4
JP - Giappone 4
MK - Macedonia 4
BE - Belgio 3
CA - Canada 3
CH - Svizzera 3
GB - Regno Unito 3
IR - Iran 3
ML - Mali 3
PH - Filippine 3
EC - Ecuador 2
ID - Indonesia 2
KE - Kenya 2
BG - Bulgaria 1
ES - Italia 1
MA - Marocco 1
MX - Messico 1
NG - Nigeria 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
TR - Turchia 1
Totale 546
Città #
Catania 53
Abidjan 42
Dublin 36
Ashburn 25
Boardman 11
Rome 10
Milan 8
Naples 8
New York 8
Kowloon 7
Council Bluffs 6
Palermo 5
Bengaluru 4
Cairo 4
Dong Ket 4
Florence 4
Mohali 4
Napoli 4
Paris 4
Aci Catena 3
Bamako 3
Belpasso 3
Bracebridge 3
Bremen 3
Central 3
Lampaul-Plouarzel 3
Minato 3
Ohrid 3
Patti 3
San Marco Evangelista 3
Syracuse 3
Zurich 3
Ambler 2
Bacolod City 2
Brussels 2
Buccinasco 2
Casamassima 2
Centrale 2
Delhi 2
Ferla 2
Foggia 2
Giugliano in Campania 2
Grosseto 2
Hangzhou 2
Kolkata 2
Lissone 2
Los Angeles 2
Marino 2
Milazzo 2
Nairobi 2
Pasadena 2
Quito 2
Saronno 2
Sunnyvale 2
Trevenzuolo 2
Vicopisano 2
Washington 2
Aarschot 1
Amsterdam 1
Avellino 1
Barcelona 1
Basking Ridge 1
Belgrade 1
Bergamo 1
Bologna 1
Casalnuovo di Napoli 1
Central District 1
Chicago 1
Cuauhtemoc 1
Dallas 1
Davis 1
Genoa 1
Gioiosa Marea 1
Grafing 1
Gravina di Catania 1
Groningen 1
Hai Duong 1
Herriman 1
Houston 1
Karachi 1
Katy 1
Lagos 1
Latina 1
Lima 1
Lisbon 1
London 1
Mahopac 1
Modugno 1
Mountain View 1
Muggiò 1
Mykolayiv 1
Norwalk 1
Nuoro 1
Paternò 1
Piraino 1
Rabat 1
Reggio Nell'emilia 1
Rewari 1
Rochester 1
Roman 1
Totale 379
Nome #
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice, file dfe4d22b-67d2-bb0a-e053-d805fe0a78d9 82
New insights in thyroid cancer and p53 family proteins, file dfe4d227-e5e3-bb0a-e053-d805fe0a78d9 56
Opportunities and challenges of liquid biopsy in thyroid cancer, file dfe4d22e-7e31-bb0a-e053-d805fe0a78d9 46
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells, file dfe4d22e-6b29-bb0a-e053-d805fe0a78d9 40
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts, file dfe4d22e-6c5b-bb0a-e053-d805fe0a78d9 36
The Role of New Technologies in Myeloproliferative Neoplasms, file dfe4d22b-ce08-bb0a-e053-d805fe0a78d9 31
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia, file dfe4d228-ff5f-bb0a-e053-d805fe0a78d9 27
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients., file dfe4d22e-db5d-bb0a-e053-d805fe0a78d9 26
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib, file dfe4d22b-5af7-bb0a-e053-d805fe0a78d9 25
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report, file dfe4d22b-886e-bb0a-e053-d805fe0a78d9 25
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic, file dfe4d22e-6d48-bb0a-e053-d805fe0a78d9 17
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma, file dfe4d22e-b665-bb0a-e053-d805fe0a78d9 17
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22), file dfe4d22b-dbce-bb0a-e053-d805fe0a78d9 16
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib, file dfe4d22c-1ae9-bb0a-e053-d805fe0a78d9 16
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment, file dfe4d22b-8b22-bb0a-e053-d805fe0a78d9 14
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53, file dfe4d229-d55d-bb0a-e053-d805fe0a78d9 13
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors, file dfe4d22b-5af8-bb0a-e053-d805fe0a78d9 13
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report, file dfe4d22c-1789-bb0a-e053-d805fe0a78d9 13
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells, file dfe4d22b-d88f-bb0a-e053-d805fe0a78d9 9
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes, file dfe4d22e-e42f-bb0a-e053-d805fe0a78d9 8
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports, file 1199ddd1-ab6a-4637-b2d3-8c85c975dcfc 7
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report, file 86029422-85af-4841-b2bf-47c3eabb5cfa 5
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report, file dfe4d22c-1787-bb0a-e053-d805fe0a78d9 2
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis, file 33438668-8c79-4538-be24-d2d87915ca7a 1
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias, file dfe4d22a-1741-bb0a-e053-d805fe0a78d9 1
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives, file dfe4d22b-d3e2-bb0a-e053-d805fe0a78d9 1
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report, file dfe4d22b-dbcc-bb0a-e053-d805fe0a78d9 1
Totale 548
Categoria #
all - tutte 1.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 1 0 0 0 1 3
2020/202119 0 3 0 0 4 4 1 0 1 0 1 5
2021/202224 0 1 2 1 1 0 1 1 1 4 9 3
2022/2023234 4 8 13 15 17 34 14 16 24 19 52 18
2023/2024266 11 34 15 14 16 68 42 45 12 9 0 0
Totale 548